Cardiovascular Health
66
15
18
31
Key Insights
Highlights
Success Rate
97% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.5%
1 terminated out of 66 trials
96.9%
+10.3% vs benchmark
3%
2 trials in Phase 3/4
10%
3 of 31 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 31 completed trials
Clinical Trials (66)
A Clinical Trial to Evaluate the Effects of an Omega-3-containing Supplement on DHA and EPA Levels in the Blood
Impact of Peanut Consumption on Stress, Immune Function, Inflammation, and Cardiovascular Health in High-Stress Individuals
A Study of Cardiac Rehabilitation Intervention to Improve Cardiovascular Health and Outcomes
Community Engagement for Cardiovascular Health Promotion in Mothers (MomHeartHealth2.0)
Health Impact 360: Advancing Physical, Social, and Mental Health Toward Cardiovascular Disease Prevention in Community Settings
HERE: Health Empowerment and Resources After Pregnancy
Beetroot Extract and Quality of Life in Adults Aged 75 and Over
Mind Your Heart Intervention for American Indian Women
JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First Year
Multidimensional Sleep Health Intervention for Couples
Aerobic Exercise: A Potential Rescue From the Negative Ramifications of Poor Sleep
Interpersonal Relationships Intervention and Cardiovascular Health
Improving the Heart Health of Home Health Aides
The Potassium Supplementation Study
St Mary's Assisted Reproductive Technology and Cardiometabolic Health: Modifiable Targets for Multimorbidity Prevention (START-HEALThY)
"11 for Health" in Pakistan - Effects on Physical Fitness, Health Knowledge and Well-being of 8-14-year-old Schoolchildren
Early Intervention to Promote Cardiovascular Health of Mothers and Children
The Effect of Women's Heart Health Awareness Program
Educational Strategy on a Vulnerable Population to Improve Cardiovascular Health and Food Insecurity
Evaluation of a Novel Insulin Sensitizer in People With Type 1 Diabetes